[Report] Cardiovascular Medicine Market Research Trends, Analysis TOC

Cardiovascular Medicine: Diagnostics, Drugs and Devices
Chapter 1 - SUMMARY
THE CARDIOVASCULAR DIAGNOSTIC, DRUG, AND DEVICE MARKETS
Summary Table: WORLDWIDE REVENUE OF CARDIOVASCULAR DIAGNOSTICS, DRUGS, AND DEVICES, THROUGH 2012 ($ BILLIONS)
Summary Figure: WORLDWIDE REVENUE OF CARDIOVASCULAR DIAGNOSTICS, DRUGS, AND DEVICES, 2005-2012 ($ BILLIONS)
Chapter 2 - OVERVIEW
- WHAT IS CARDIOVASCULAR (CV) DISEASE?
- CAUSES OF CARDIOVASCULAR DISEASE
- CAUSES OF CARDIOVASCULAR DISEASE (CONTINUED)
- CARDIOVASCULAR DIAGNOSTICS
- CARDIOVASCULAR MEDICINE
- CARDIOVASCULAR DEVICES
Chapter 3 - CARDIOVASCULAR DISEASES
- DISEASES OF THE HEART (CARDIO) AND DISEASES OF THE BLOOD VESSELS (VASCULAR)
- DISEASES OF THE HEART
  - Coronary Artery Disease (CAD)
  - Coronary Heart Disease (CHD)
  - Cardiomyopathy
  - Valvular Heart Disease
  - Pericardial Disease
  - Congenital Heart Disease
  - Heart Failure
DISEASE OF BLOOD VESSELS
- Arteriosclerosis and Atherosclerosis
- High Blood Pressure
- Stroke
- Aneurysm
- Peripheral Arterial Disease and Claudication (PAD)
- Vasculitis
- Venous Incompetence
- Venous Thrombosis
- Varicose Veins
- Lymphedema
EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE
- Global Distribution Pattern in 2004
- Age
- Gender
- Role of Risk Factors
- Risk Factors
- Psychological and Social Factors
- Prevention of Cardiovascular Disease
Chapter 4 - PREVALANCE OF CARDIOVASCULAR DISEASES
- MAJOR CAUSE OF DEATH
  - THE EPIDEMIOLOGICAL TRANSITION
  - PREVALENCE OF HEART DISEASE IN VARIOUS CATEGORIES
    - Age
    - Gender
    - Race/ Ethnicity
    - Education
Table 1 PREVALENCE OF STROKE, MYOCARDIAL INFARCTION, AND ANGINA PECTORIS BY VARIOUS CATEGORIES, 2005
Figure 1 PREVALENCE OF STROKE, MYOCARDIAL INFARCTION, AND ANGINA PECTORIS BY AGE GROUP, 2005 (%)
Figure 2 PREVALENCE OF STROKE, MYOCARDIAL INFARCTION, AND ANGINA PECTORIS BY GENDER, 2005 (%)
Figure 3 PREVALENCE OF STROKE, MYOCARDIAL INFARCTION, AND ANGINA PECTORIS BY RACE/ETHINICITY, 2005 (%)
Figure 4 PREVALENCE OF STROKE, MYOCARDIAL INFARCTION, AND ANGINA PECTORIS BY EDUCATION 2005 (%)
PREVALENCE OF CARDIOVASCULAR DISEASES IN THE U.S.
Table 2 PREVALENCE OF CARDIOVASCULAR DISEASES IN U.S., 2005 (MILLION PEOPLE)
Figure 5 PREVALENCE OF CARDIOVASCULAR DISEASES IN THE U.S., 2005 (MILLION PEOPLE)
- COST OF CARDIOVASCULAR DISEASES IN THE U.S.
Table 3 COST OF CARDIOVASCULAR DISEASES IN U.S. THROUGH 2012 ($ BILLIONS)
Figure 6 COST OF CARDIOVASCULAR DISEASES IN THE U.S., 2005-2012 ($ BILLIONS)
- PREVALENCE AND COST OF CARDIOVASCULAR DISEASES IN EUROPE
- MORTALITY DUE TO CARDIOVASCULAR DISEASES
- U.S.
Table 4 MORTALITY DUE TO CARDIOVASCULAR DISEASES IN THE U.S., 2005 (%)
Table 4 (CONTINUED)
Figure 7 MORTALITY DUE TO CARDIOVASCULAR DISEASES IN THE U.S. 2005 (%)
- Europe
Table 5 MORTALITY DUE TO CARDIOVASCULAR DISEASES IN EUROPE, 2005 (%)
Figure 8 MORTALITY DUE TO CARDIOVASCULAR DISEASES IN THE U.S., 2005 (%)
Chapter 5 - REGULATORY ISSUES
- CARDIOVASCULAR DRUGS APPROVED BY FDA
Table 6 CARDIOVASCULAR DRUGS APPROVED BY FDA, 2002-2007*
Figure 9 CARDIOVASCULAR DRUGS APPROVED BY FDA, 2002-2007*
- CARDIOVASCULAR DEVICES APPROVED BY THE FDA
Table 7 CARDIOVASCULAR DEVICES APPROVED BY THE FDA, 2002-2007*
Table 7 (CONTINUED)
Table 7 (CONTINUED)
Figure 10 CARDIOVASCULAR DEVICES APPROVED BY THE FDA 2002-2007*
- CARDIOVASCULAR DRUGS RECALLED BY FDA
Table 8 CARDIOVASCULAR DRUGS RECALLED BY THE FDA, 2002-2007*
- CARDIOVASCULAR DEVICES RECALLED BY FDA
Table 9 CARDIOVASCULAR DEVICES RECALLED BY THE FDA, 2002-2007*
Table 9 (CONTINUED)
Figure 11 CARDIOVASCULAR DEVICES RECALLED BY FDA, 2002-2007*
Figure 11 (CONTINUED)
- NEW DRUG APPLICATIONS
  - NEW DRUG APPLICATIONS (CONTINUED)
  - NEW DRUG APPLICATIONS (CONTINUED)
Chapter 6 - CARDIOVASCULAR DIAGNOSTICS
- DIAGNOSTICS DEFINITION
- IN VITRO DIAGNOSTIC
- BIOMARKERS
  - Aspartate Aminotransferase (AST/GOT)
  - Lactate Dehydrogenase and its Isoenzyme LD
  - Creatine Kinase (CK) and its Isoenzyme MB
  - Myoglobin
  - Cardiac Troponins
    - Reasons behind the Replacement of CKMB with Troponins
    - Myoglobin/Carbonic Anhydrase III Ratio
    - Glycogen Phosphorylase Isoenzyme BB
    - Heart Type Fatty Acid Binding Protein
- COMPARISON BETWEEN CTNT AND CTNL
  - Natriuretic Peptides as Cardiac Biomarkers
Table 10 NT-PROBNP IN ACUTE SITUATIONS
Table 11 NT-PROBNP IN PRIMARY CARE SETTING
- POINT-OF-CARE TESTING
  - NEED FOR THE POCT
Table 12 ADVANTAGES OF POINT OF CARE TESTING
Table 13 DISADVANTAGES OF POINT OF CARE TESTING
- Past, Present, and Future of Point-of-Care Testing
  - Past
  - Present
  - Future
- DETERMINING WHETHER TO USE POC CARDIAC TESTING IN THE ED
  - Considerations of Turnaround Times
  - The Importance of Quantitative Results
  - Concerns about Standardization
- VENUES FOR POC TESTING
Table 14 VENUES FOR POC TESTING
- IN VIVO DIAGNOSTICS
  - ECHOCARDIOGRAPHY
    - Need of the Echocardiography
Table 15 TYPES OF ECHOCARDIOGRAMS
- ULTRASOUND
Table 16 TYPES OF DOPPLER ULTRASOUND
- Advantages of Ultrasound
MRI
- Need of MRI Scan
- POSITRON EMISSION TOMOGRAPHY
- COMPUTED TOMOGRAPHY
  - Electron-Beam Computed Tomography (EBCT or Ultrafast CT)
    - Electron-Beam Computed (Continued)
Chapter 7 - CARDIOVASCULAR THERAPY
- CARDIOVASCULAR DRUGS
- ANTI-ANGINAL AGENTS
Table 17 COMMONLY USED ANTI-ANGINAL AGENTS
- ANTI-ARRHYTHMIC AGENTS
Table 18 COMMONLY USED ANTI-ARRHYTHMIC AGENTS
- ANTI-HYPERTENSIVE DRUGS
Table 19 COMMONLY USED ANTI-HYPERTENSIVE AGENTS
- ANTI-THROMBOTIC AGENTS
- BLOOD LIPID LOWERING AGENTS
Table 20 COMMONLY USED BLOOD LIPID LOWERING AGENTS
- DRUGS USED TO TREAT CONGESTIVE HEART FAILURE
Table 21 COMMONLY USED DRUGS TO TREAT CONGESTIVE HEART FAILURE
- CARDIOVASCULAR DEVICES
- PACEMAKERS
Table 22 PACEMAKERS
- Defibrillators
- Manual External Defibrillators
  - Manual Internal Defibrillator
  - Automated External Defibrillator
  - Semi-automated External Defibrillator
  - Implantable Cardioverter Defibrillator
- Drug-Eluting Stents (DES)
- Catheters
- Valves
  - Mechanical Heart Valve
  - Biological Heart Valve
- Ventricular Assist Device
- Guidewires
- Artificial Heart
CARDIAC RESYNCHRONIZATION THERAPY
- Cardiac Resynchronization Therapy
- Cardiac Resynchronization Therapy Devices
- Difference between Biventricular Pacemaker and Standard Pacemaker
- Use of CRT
- Benefits of CRT
- Potential Risks with Biventricular Pacemakers
Chapter 8 - INDUSTRY STRUCTURE
- CARDIOVASCULAR DIAGNOSTICS
- CARDIAC BIOMARKERS
Table 23 PRESENT CARDIAC MARKER TESTING
- Market Shares for Companies Providing Biomarker Tests
Table 24 MARKET SHARE OF COMPANIES PROVIDING BIOMARKER TESTS, 2006 (%)
Figure 12 MARKET SHARE OF COMPANIES PROVIDING BIOMARKER TESTS, 2006 (%)
- Effect of POCT on the Growth of Cardiac Biomarker Testing in Laboratory
- POINT OF TESTING FOR CARDIAC BIOMARKERS
Table 25 PRESENT POINT-OF-CARE TESTING FOR CARDIAC BIOMARKERS
- Market Shares for Companies Providing Biomarker Tests
Table 26 MARKET SHARE OF COMPANIES PROVIDING POINT-OF-CARE TESTING FOR CARDIAC BIOMARKERS, 2006 (%)
Figure 13 MARKET SHARE OF COMPANIES PROVIDING POINT-OF CARE TESTING FOR CARDIAC BIOMARKERS, 2006 (%)
- Factors Influencing the Growth of Point-of-Care Testing
- Challenges for the Manufacturers
- IN-VIVO DIAGNOSTICS
Table 27 PRESENT IMAGING SYSTEMS FOR IN-VIVO DIAGNOSIS
Market Shares for Companies Providing In-Vivo Diagnostics
Table 28 MARKET SHARE OF COMPANIES PROVIDING IN-VIVO DIAGNOSTICS, 2006 (%)
Figure 14 MARKET SHARE OF COMPANIES PROVIDING IN-VIVO DIAGNOSTICS, 2006 (%)
- Factors Affecting the Growth of Cardiac Imaging or In vivo Diagnostics
- CARDIOVASCULAR DRUGS
- ANTI-ANGINAL AGENTS
Table 29 GLOBAL MARKET LEADERS OF ANTI-ANGINAL AGENTS
- Market Shares for Anti-anginal Agents
Table 30 MARKET SHARE OF COMPANIES MANUFACTURING ANTI-ANGINAL AGENTS, 2006 (%)
Figure 15 MARKET SHARE OF COMPANIES MANUFACTURING ANTI-ANGINAL AGENTS, 2006 (%)
- ANTI-ARRYHTHMIC AGENTS
Table 31 GLOBAL MARKET LEADERS OF ANTI-ARRHYTHMIC AGENTS
- Market Shares for Anti-arrhythmic Agents
Table 32 MARKET SHARE OF COMPANIES MANUFACTURING ANTI-ARRHYTHMIC AGENTS, 2006 (%)
Figure 16 MARKET SHARE OF COMPANIES MANUFACTURING ANTI-ARRHYTHMIC AGENTS, 2006 (%)
- ANTI-HYPERTENSIVE AGENTS
Table 33 GLOBAL MARKET LEADERS OF ANTI-HYPERTENSIVE AGENTS
- Market Shares for Anti-hypertensive Agents
Table 34 MARKET SHARE OF COMPANIES MANUFACTURING ANTI-HYPERTENSIVE AGENTS, 2006 (%)
Figure 17 MARKET SHARE OF COMPANIES MANUFACTURING ANTI-HYPERTENSIVE AGENTS, 2006 (%)
ANTI-THROMBOTIC AGENTS
Table 35 GLOBAL MARKET LEADERS OF ANTI-THROMBOTIC AGENTS
Market Shares for Anti-thrombotic Agents
Table 36 MARKET SHARE OF COMPANIES MANUFACTURING ANTI-THROMBOTIC AGENTS, 2006 (%)
Figure 18 MARKET SHARE OF COMPANIES MANUFACTURING ANTI-THROMBOTIC AGENTS, 2006 (%)
- BLOOD LIPID LOWERING AGENTS
Table 37 GLOBAL MARKET LEADERS OF BLOOD LIPID LOWERING AGENTS
- Market Shares for Blood Lipid Lowering Agents
Table 38 MARKET SHARE OF COMPANIES MANUFACTURING BLOOD LIPID LOWERING AGENTS, 2006 (%)
Figure 19 MARKET SHARE OF COMPANIES MANUFACTURING BLOOD LIPID LOWERING AGENTS, 2006 (%)
- DRUGS TREATING CONGESTIVE HEART FAILURE
Table 39 GLOBAL MARKET LEADERS OF DRUGS TREATING CONGESTIVE HEART FAILURE
- Market Shares for Drugs Treating Congestive Heart Failure
Table 40 MARKET SHARE OF COMPANIES MANUFACTURING DRUGS TREATING CONGESTIVE HEART FAILURE, 2006 (%)
Table 40 (CONTINUED)
Figure 20 MARKET SHARE OF COMPANIES MANUFACTURING DRUGS TREATING CONGESTIVE HEART FAILURE, 2006 (%)
- FACTORS AFFECTING THE SALES OF CARDIOVASCULAR DRUGS
  - Price Control/ Price pressure
  - Expiration of Patents
- MAJOR FACTORS FOR FUTURE GROWTH
  - Life Expectancy
  - Access of Senior Citizens to Prescription Drugs
  - Patent Protection
  - Drugs Portfolio Management
  - Significant Potential of Developing Countries
CARDIOVASCULAR DEVICES
- PACEMAKERS
Table 41 GLOBAL MARKET LEADERS OF MANUFACTURERS OF PACEMAKERS
- Market Shares of Companies Manufacturing Pacemakers
Table 42 MARKET SHARE OF COMPANIES MANUFACTURING PACEMAKERS, 2006 (%)
Figure 21 MARKET SHARE OF COMPANIES MANUFACTURING PACEMAKERS, 2006 (%)
- CARDIOVERTER DEFIBRILLATORS
Table 43 GLOBAL MARKET LEADERS OF MANUFACTURERS OF CONVENTIONAL CARDIOVERTER DEFIBRILLATORS
Table 44 GLOBAL MARKET LEADERS OF MANUFACTURERS OF CRT-DEFIBRILLATORS
- Market Shares of Companies Manufacturing Conventional Cardioverter Defibrillators
Table 45 MARKET SHARE OF COMPANIES MANUFACTURING CONVENTIONAL CARDIOVERTER DEFIBRILLATORS, 2006 (%)
Figure 22 MARKET SHARE OF COMPANIES MANUFACTURING CONVENTIONAL CARDIOVERTER DEFIBRILLATORS, 2006 (%)
- Market Shares of Companies Manufacturing CRT-Defibrillators
Table 46 MARKET SHARE OF COMPANIES MANUFACTURING CRT-DEFIBRILLATORS, 2006 (%)
Figure 23 MARKET SHARE OF COMPANIES MANUFACTURING CRT-DEFIBRILLATORS, 2006 (%)
- DRUG ELUTING STENTS
Table 47 GLOBAL MARKET LEADERS OF MANUFACTURERS OF DRUG ELUTING STENTS
Market Shares of Companies Manufacturing Drug Eluting Stents
Table 48 MARKET SHARE OF COMPANIES MANUFACTURING DRUG ELUTING STENTS, 2006 (%)
Figure 24 MARKET SHARE OF COMPANIES MANUFACTURING DRUG ELUTING STENTS, 2006 (%)
- CATHETERS
Table 49 GLOBAL MARKET LEADERS OF MANUFACTURERS OF CATHETERS
Table 49 (CONTINUED)
- Market Shares of Companies Manufacturing Catheters
Table 50 MARKET SHARE OF COMPANIES MANUFACTURING CATHETERS, 2006 (%)
Figure 25 MARKET SHARE OF COMPANIES MANUFACTURING CATHETERS, 2006 (%)
- HEART VALVES
Table 51 GLOBAL MARKET LEADERS OF MANUFACTURERS OF HEART VALVES
- Market Shares of Companies Manufacturing Heart Valves
Table 52 MARKET SHARE OF COMPANIES MANUFACTURING HEART VALVES, 2006 (%)
Figure 26 MARKET SHARE OF COMPANIES MANUFACTURING HEART VALVES, 2006 (%)
- VENTRICULAR ASSIST DEVICE
Table 53 GLOBAL MARKET LEADERS OF MANUFACTURERS OF VENTRICULAR ASSIST DEVICES
- Market Shares of Companies Manufacturing Ventricular Assist Devices
Table 54 MARKET SHARE OF COMPANIES MANUFACTURING VENTRICULAR ASSIST DEVICES, 2006 (%)
Figure 27 MARKET SHARE OF COMPANIES MANUFACTURING VENTRICULAR ASSIST DEVICES, 2006 (%)
- GUIDE WIRES
Table 55 GLOBAL MARKET LEADERS OF MANUFACTURERS OF GUIDE WIRES
- Market Shares of Companies Manufacturing Guidewires
Table 56 MARKET SHARE OF COMPANIES MANUFACTURING GUIDEWIRES, 2006 (%)
Figure 28 MARKET SHARE OF COMPANIES MANUFACTURING GUIDEWIRES, 2006 (%)
- FACTORS AFFECTING THE SALES OF CARDIOVASCULAR DEVICES
  - Aging Baby-Boomers
  - Regulation
  - Competitive Landscape of Technology
  - Shortening of Patent Lives
  - Business Taxes
Chapter 9 - MARKET ANALYSIS OF CARDIOVASCULAR DIAGNOSTICS
- CARDIAC BIOMARKERS
Table 57 GLOBAL SALES OF CARDIAC BIOMARKERS, THROUGH 2012 ($ MILLIONS)
Figure 29 GLOBAL SALES OF CARDIAC BIOMARKERS, 2005-2012 ($ MILLIONS)
- CARDIAC MARKER TESTING BY TYPE
Table 58 ESTIMATED WORLDWIDE MARKET FOR CARDIAC MARKER TESTING BY TYPE, THROUGH 2012 ($ MILLIONS)
Figure 30 GLOBAL SALES OF CARDIAC BIOMARKERS, BY TYPE, 2005-2012 ($ MILLIONS)
- POINT-OF-CARE TESTING
Table 59 GLOBAL SALES OF POINT-OF-CARE TESTING, THROUGH 2012 ($ MILLIONS)
Figure 31 GLOBAL SALES OF POINT-OF-CARE TESTING, 2005-2012 ($ MILLIONS)
- IN VIVO DIAGNOSTICS
- In Vivo Diagnostics (Continued)
Table 60 GLOBAL SALES OF IN-VIVO DIAGNOSTICS, THROUGH 2012 ($ MILLIONS)
Figure 32 GLOBAL SALES OF IN VIVO DIAGNOSTICS. 2005-2012 ($ MILLIONS)
TOTAL MARKET SHARES OF CARDIOVASCULAR DIAGNOSTICS WORLDWIDE
Table 61 WORLDWIDE MARKET SHARE OF CARDIOVASCULAR DIAGNOSTICS, 2006 (%)
Figure 33 WORLDWIDE MARKET SHARE OF CARDIOVASCULAR DIAGNOSTICS, 2006 (%)
Chapter 10 - MARKET ANALYSIS OF CARDIOVASCULAR DRUGS
- ANTI-ANGINAL AGENTS
Table 62 GLOBAL SALES OF ANTI-ANGINAL DRUGS, THROUGH 2012 ($ BILLIONS)
Figure 34 GLOBAL SALES OF ANTI-ANGINAL DRUGS, 2005-2012($ BILLIONS)
- ANTI-ARRHYTHMIC AGENTS
Table 63 GLOBAL SALES OF ANTI-ARRHYTHMIC DRUGS, THROUGH 2012 ($ BILLIONS)
Figure 35 GLOBAL SALES OF ANTI-ARRHYTHMIC DRUGS, 2005-2012 ($ BILLIONS)
- ANTI-HYPERTENSIVE AGENTS
Table 64 GLOBAL SALES OF ANTI-HYPERTENSIVE DRUGS, THROUGH 2012 ($ BILLIONS)
Figure 36 GLOBAL SALES OF ANTI-HYPERTENSIVE DRUGS, 2005-2012 ($ BILLIONS)
- ANTI-THROMBOTIC AGENTS
Table 65 GLOBAL SALES OF ANTI-THROMBOTIC DRUGS, THROUGH 2012 ($ BILLIONS)
Figure 37 GLOBAL SALES OF ANTI-THROMBOTIC DRUGS, 2005-2012 ($ BILLIONS)
- BLOOD LIPID LOWERING AGENTS
Table 66 GLOBAL SALES OF BLOOD LIPID LOWERING DRUGS, THROUGH 2012 ($ BILLIONS)
Figure 38 GLOBAL SALES OF BLOOD LIPID LOWERING DRUGS, 2005-2012 ($ BILLIONS)
- DRUGS USED TO TREAT CONGESTIVE HEART FAILURE
Table 67 GLOBAL SALES OF DRUGS USED TO TREAT CONGESTIVE HEART FAILURE, THROUGH 2012 ($ BILLIONS)
Figure 39 GLOBAL SALES OF DRUGS USED TO TREAT CONGESTIVE HEART FAILURE, 2005-2012 ($ BILLIONS)
- TOTAL WORLDWIDE MARKET SHARES OF CARDIOVASCULAR DRUGS
Table 68 MARKET SHARE OF CARDIOVASCULAR DRUGS, 2006 (%)
Figure 40 MARKET SHARE OF CARDIOVASCULAR DRUGS, 2006 (%)
Chapter 11 - CARDIOVASCULAR DEVICES MARKET ANALYSIS
- PACEMAKERS
Table 69 GLOBAL SALES OF PACEMAKERS, THROUGH 2012 ($ MILLIONS)
Figure 41 GLOBAL SALES OF PACEMAKERS, 2005-2012 ($ MILLIONS)
- IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
Table 70 GLOBAL SALES OF CONVENTIONAL IMPLANTABLE CARDIOVERTER DEVICES, THROUGH 2012 ($ MILLIONS)
Figure 42 GLOBAL SALES OF IMPLANTABLE CARDIOVERTER DEVICES, 2005-2012 ($ MILLIONS)
Table 71 GLOBAL SALES OF CRT-DEFIBRILLATORS, THROUGH 2012 ($ MILLIONS)
Figure 43 GLOBAL SALES OF IMPLANTABLE CRT-DEFIBRILLATORS, 2005-2012 ($ MILLIONS)
DRUG ELUTING STENTS (DES) AND GRAFTS
Drug Eluting Stents (DES) and Grafts (Continued)
Table 72 GLOBAL SALES OF DRUG ELUTING STENTS AND GRAFTS, THROUGH 2012 ($ MILLIONS)
Figure 44 GLOBAL SALES OF DRUG ELUTING STENTS AND GRAFTS, 2005-2012 ($ MILLIONS)
- CATHETERS
Table 73 GLOBAL SALES OF CATHETERS, THROUGH 2012 ($ MILLIONS)
Figure 45 GLOBAL SALES OF CATHETERS, 2005-2012 ($ MILLIONS)
- HEART VALVES
Table 74 GLOBAL SALES OF HEART VALVES, THROUGH 2012 ($ MILLIONS)
Figure 46 GLOBAL SALES OF HEART VALVES, THROUGH 2012 ($ MILLIONS)
- VENTRICULAR ASSIST DEVICES
Table 75 GLOBAL SALES OF VENTRICULAR ASSIST DEVICES, THROUGH 2012 ($ MILLIONS)
Figure 47 GLOBAL SALES OF VENTRICULAR ASSIST DEVICES, 2005-2012 ($ MILLIONS)
- GUIDEWIRES
Table 76 GLOBAL SALES OF GUIDEWIRES, THROUGH 2012 ($ MILLIONS)
Figure 48 GLOBAL SALES OF GUIDEWIRES, 2005-2012 ($ MILLIONS)
- ARTIFICIAL HEART
- TOTAL MARKET SHARES OF CARDIOVASCULAR DEVICES WORLDWIDE
Table 77 MARKET SHARE OF CARDIOVASCULAR DEVICES, 2006 (%)
Figure 49 MARKET SHARE OF CARDIOVASCULAR DEVICES, 2006 (%)
Chapter 12 - NEW DEVELOPMENTS/ TECHNOLOGICAL INNOVATIONS
- DIAGNOSTICS
  - SIEMENS MEDICAL SOLUTIONS
  - NEUROSONIX LTD
  - UNIVERSITY HOSPITAL MANNHEIM AND OSPEDALI RIUNITI DI BERGAMO
  - SORIN
  - PHILIPS
  - TOPSPIN MEDICAL
  - SONOSITE, INC.
  - DATASCOPE CORPORATION
  - RESPONSE BIOMEDICAL
  - ASTRAZENECA
  - BMS & PFIZER
  - DECODE GENETICS
  - ENCYSIVE PHARMACEUTICALS INC.
  - EPIX PHARMACEUTICALS, INC.
  - LEXICON PHARMACEUTICALS
  - MERCK & COMPANY
  - MOMENTA PHARMACEUTICALS, INC.
  - NILE THERAPEUTICS, INC.
  - PHARMACOPEIA
  - SANOFI-AVENTIS
  - TAKEDA PHARMACEUTICAL
  - UNIVERSITY OF NORTH CAROLINA
- DEVICES
  - ABBOTT
  - ABIOMED, INC.
  - ATS MEDICAL
  - CARDIATIS
  - CRYOCATH TECHNOLOGIES, INC.
  - CRYOCOR, INC.
  - EDWARD LIFESCIENCES
  - MEDTRONIC, INC.
  - METHODIST DEBAKEY HEART CENTER
  - ST. JUDE MEDICAL, INC.
- STEM CELLS AND HEART DISEASE
  - STEM CELLS AND HEART DISEASE (CONTINUED)
Chapter 13 - PATENT ANALYSIS
- TOTAL PATENTS
  - PATENTS BY YEAR
Table 78 TOTAL NUMBER OF SIGNIFICANT PATENTS, 2005-2007
Figure 50 NUMBER OF PATENTS, 2005-2007
Figure 51 NUMBER OF PATENTS, SHARE BY YEAR, 2005-2007 (%)
- PATENTS BY COUNTRY
Table 79 TOTAL NUMBER OF PATENTS BY COUNTRY, 2005-2007
Figure 52 TOTAL NUMBER OF PATENTS BY COUNTRY, 2005-2007
- DIAGNOSTICS PATENTS
- PATENTS BY YEAR
Table 80 PATENTS FOR DIAGNOSTICS BY YEAR, 2005-2007
Figure 53 PATENTS FOR DIAGNOSTICS BY YEAR, 2005-2007
PATENTS BY COUNTRY
Table 81 PATENTS BY COUNTRY FOR DIAGNOSTICS, 2005-2007
Figure 54 PATENTS BY COUNTRY FOR DIAGNOSTICS, 2005-2007
- PATENTS BY COMPANY
Table 82 NUMBER OF PATENTS BY COMPANY FOR DIAGNOSTICS
Table 82 (CONTINUED)
Figure 55 TOTAL NUMBER OF PATENTS BY COMPANY FOR DIAGNOSTICS, 2005-2007
- PATENTS BY ASSIGNEE
Table 83 NUMBER OF PATENTS BY ASSIGNEE FOR DIAGNOSTICS, 2005-2007
Figure 56 NUMBER OF PATENTS BY ASSIGNEE FOR DIAGNOSTICS, 2005-2007
- DRUG PATENTS
- PATENTS BY COUNTRY
Table 84 PATENTS BY COUNTRY FOR DRUGS, 2005-2007
Figure 57 PATENTS BY COUNTRY FOR DRUGS, 2005-2007
- PATENTS BY COMPANY
Table 85 NUMBER OF PATENTS BY COMPANY FOR DRUGS, 2005-2007
Table 85 (CONTINUED)
Figure 58 TOTAL NUMBER OF PATENTS BY COMPANY FOR DRUGS, 2005-2007
- Patents by Assignee
Table 86 NUMBER OF PATENTS BY ASSIGNEE FOR DEVICES, 2005-2007
Figure 59 NUMBER OF PATENTS BY ASSIGNEE FOR DRUGS, 2005-2007
- DEVICE PATENTS
- PATENTS BY YEAR
Table 87 PATENTS FOR DEVICES BY YEAR, 2005-2007
Figure 60 PATENTS FOR DEVICES BY YEAR, 2005-2007
- PATENTS BY COUNTRY
Table 88 PATENTS BY COUNTRY FOR DEVICES, 2005-2007
Figure 61 PATENTS BY COUNTRY FOR DEVICES, 2005-2007
- PATENTS BY COMPANY
Table 89 NUMBER OF PATENTS BY COMPANY FOR DEVICES, 2005-2007
Table 89 (CONTINUED)
Figure 62 TOTAL NUMBER OF PATENTS BY COMPANY FOR DEVICES, 2005-2007
- PATENTS BY ASSIGNEE
Table 90 NUMBER OF PATENTS BY ASSIGNEE FOR DEVICES, 2005-2007
Figure 63 NUMBER OF PATENTS BY ASSIGNEE FOR DEVICES, 2005-2007
Chapter 14 - COMPANY PROFILES FOR DIAGNOSTICS
- ABBOTT LABORATORIES INC.
- AXIS-SHIELD PLC
- BAYER AG
- BECKMAN COULTER INC.
- BIOMÉRIEUX INC.
- BIOSITE INCORPORATED
- BIOSOUND ESAOTE INC.
- CAMBRIDGE HEART INC.
- CHOLESTECH
- COVIDIEN
- DADE BEHRING INC.
- DELTEX MEDICAL GROUP PLC
- EPIX PHARMACEUTICALS, INC.
- EP MEDSYSTEMS
- FONAR CORPORATION
- GE HEALTHCARE
- HYPERTENSION DIAGNOSTIC INC.
- INVERNESS MEDICAL INNOVATIONS, INC
- MALLINCKRODT
- MEDISON AMERICA INC.
- MORTARA INSTRUMENT INC.
- OLYMPUS AMERICA INC.
- ORTHO-CLINICAL DIAGNOSTICS, INC. (JOHNSON & JOHNSON CO.)
- PHILIPS MEDICAL SYSTEM
- PREMD INC.
- RESPONSE BIOMEDICAL CORP.
- ROCHE HOLDING
- SIEMENS
- SONOSITE
- SONOSITE (CONTINUED)
- Chapter 15 - COMPANY PROFILES FOR DRUGS
- ABBOTT LABORATORIES INC.
- ASTRAZENECA PLC
- BAYER HEALTHCARE PHARMACEUTICALS INC.
- BIOVAIL CORPORATION
- BOEHRINGER INGELHEIM
- BRISTOL-MYERS SQUIBB COMPANY
- CV THERAPEUTICS INC.
- HOFFMAN-LA ROCHE INC.
- KRKA GROUP
- LES LABORATORIES SERVIER
- MERCK & CO. INC.
- MERCK KGAA
- NOVARTIS AG
- PFIZER INC.
- SANOFI AVENTIS
- SCHERING PLOUGH
- SOLVAY S.A.
- UCB
- WYETH
- ZENTIVA N.V.
Chapter 16 - COMPANY PROFILES FOR DEVICES
- AMBU INTERNATIONAL AS
- ANGIODYNAMICS INC.
- ASAHI INTECC CO., LTD.
- ATS MEDICAL INC.
- BACCHUS VASCULAR
- BIOHEART INC.
- BIOSENSOR INTERNATIONAL GROUP
- BOSTON SCIENTIFIC CORPORATION
- CARDIMA INC.
- CONOR MEDSYSTEMS, LLC
- COOK GROUP
- CORDIS CORPORATION (JOHNSON &JOHNSON CO.)
- COREVALVE
- C.R. BARD INC.
- CRYOCATH
- CRYOCOR
- DATASCOPE CORP.
- EDWARD LIFESCIENCES CORP.
- GOODMAN CO. LTD.
- HANSEN MEDICAL
- HOSPIRA
- JAPAN LIFELINE
- MEDTRONIC
- MERIT MEDICAL SYSTEM INC.
- NMT MEDICAL INC.
- POSSIS MEDICAL
- SORIN GROUP
- ST.JUDE MEDICAL
- TERUMO
- THORATEC
- VASCULAR SOLUTIONS INC.
- WORLD HEART CORP.
- ZOLL MEDICAL INC.
Chapter 17 - APPENDIX
- Table 91 ACRONYMS
- Table 91 (CONTINUED)
- Table 91 (CONTINUED)

Cardiovascular Medicine: Diagnostics, Drugs and Devices

Table of Contents